- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
Showing 1 - 2 of 2
-
Case Report
Varlas VN, Angelescu G, Rhazi Y, Nasui BA, Pop AL, Gheorghiu ML
Challenges of an Ovarian Neuroendocrine Metastasis of Advanced Smallcell Lung Carcinoma – Literature Review and Case ReportActa Endo (Buc) 2021 17(2): 251-258 doi: 10.4183/aeb.2021.251
AbstractMetastatic tumors account for 5-10% of all ovarian malignancies. They are usually bilateral tumors with a multinodular surface and extensive extra ovarian spread. Lung cancer is a rare source (0.3% of metastatic ovarian tumors). Among synchronous primary cancers, ovarian cancer is most frequently associated with endometrial cancer. The differential diagnosis between a primary ovarian carcinoma, synchronous primary cancers, and metastatic ovarian carcinoma is very important, as the treatment and prognosis are markedly different. We report the case of a 25-year-old woman who had been diagnosed and treated for stage IIIB small cell lung carcinoma (SCLC). Imaging undertaken for abdominal pain revealed a unilateral 8.5 cm ovarian tumor for which adnexectomy was performed. Histology and immunohistochemistry led to the diagnosis of ovarian metastasis from SCLC, a high-grade neuroendocrine lung tumor. This patient’s particular features, all infrequent in a metastatic tumor, are the lesion’s unilaterality (atypical for ovarian metastases in other cancers, but often observed in SCLC), the smooth ovarian surface with intact capsule, and the absence of intra-abdominal dissemination. The patient developed liver and vertebral metastases. This report focuses on the differential diagnosis between primary and metastatic ovarian neoplasms. We performed an extensive search of the literature on SCLC and ovarian metastases. Immunohistochemistry is essential for diagnosis when imaging and the pathological evaluation of the ovarian tumor cannot make the differential diagnosis. -
Endocrine Care
Varlas V, Gheorghiu ML
Fetal thyroid status in normal pregnancy and premature birth euthyroid women without goitre from areas with or without iodine deficiencyActa Endo (Buc) 2006 2(4): 403-418 doi: 10.4183/aeb.2006.403
AbstractObjective. This study assesses, in patients from counties with iodine deficiency (ID) and without ID, the concentrations of thyroid hormones in newborns (cord blood) and mothers at delivery, maternal and fetal thyroid volumes (less than 24 hours before delivery) and maternal urinary iodine at delivery. Another aim of this paper is to identify the interrelations between maternal and neonatal thyroid functions in the premature and full term delivery.\r\nMethods. In this study there were 83 mothers without thyroid pathology (goitre included) aged 26.51 ? 4.88 years, range 16-38 years) and their 83 newborns immediately after delivery. Four groups were identified: group A - 13 mothers from iodine sufficient area (IS) who delivered prematurely, group B - 13 mothers from iodine deficient area (ID), who delivered prematurely, group C - 38 mothers from IS area who delivered at term and group D - 19 mothers from ID area who delivered at term. The serum concentrations of TSH, total (T)T4, free (F)T4, TT3 and FT3 were evaluated by a microparticle enzyme immunoassay (MEIA). The thyroid volumes in mothers and their fetuses were measured by ultrasonography with a high resolution equipment (Accuvix XQ).\r\nResults. The values of TSH in newborns (cord blood serum), expressed as mean ? standard deviation (SD), were significantly higher in groups from ID areas (B+D) vs. groups from IS areas (A+C) (p<0.03). TSH levels were higher in group D vs. group C (6.62 ? 4.53 mU/L vs. 5.46 ? 2.83 mU/L [p<0.03]). The values of TT4 in newborns were significantly lower in group B vs group D (8.09 ? 1.68 ?g/dl vs. 9.45 ? 2.23 ?g/dl [p<0.05]), in premature group (A+B) vs term group (C+D) [p<0.007] and in groups from ID areas (B+D) vs. IS groups (A+C) vs [p<0.01]. Thyroid volumes (TV) in fetuses from IS areas (A+C) were lower than in ID areas (B+D) (p<0.002), but TV was similar in fetuses born at term or prematurely. Serum TSH levels in newborns (71.73 ? 26.54 ?g/l) were negatively correlated with maternal urinary iodine (r = -0.827, p<0.0001). Serum TSH in newborn was not correlated with maternal TSH in any group (A-D). The TV in fetuses (1.25 ? 0.1 ml) were highly correlated with TSH in newborns (r = 0.83, p<0.001), negatively correlated with maternal urinary iodine (r = -0.81, p<0.001) and correlated with maternal TV (17.12 ? 1.82 ml) (r = 0.44, p<0.02).\r\nConclusions. The status of the thyroid hormones and thyroid volumes in the newborn was dependent on the severity of iodine deficiency and in a less proportion on prematurity. The fetus is more sensitive to iodine deficiency than the mother.
Showing 1 - 2 of 2